Regeneron Pharmaceuticals Inc Market Cap
Data as of August 04, 2026
Market Cap
$79.94B
Stock Price
$759.24
Shares Outstanding
$105M
Classification
Large Cap
How It's Calculated
$79.94B = $759.24 × $105M
What This Means
Regeneron Pharmaceuticals Inc has a market capitalization of $79.94B, classifying it as Large Cap — a major company by market standards. Market cap represents the total value of all outstanding shares and is a key indicator of a company's size.
About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc (REGN) operates in the Biotechnology sector, specifically in Biotechnology. With a market capitalization of about $79.94B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $759.24, within a 52-week range of $541.00 to $821.11 (-7.5% from the high, +40.3% from the low). Beta of 0.19 indicates relatively lower volatility versus the market.
Trailing profit margin is about 29.6%, signaling a strong profit margin relative to many peers.
Understanding This Metric
Market capitalization sums the market value of all outstanding shares. It helps classify Regeneron Pharmaceuticals Inc by size — mega-cap, large-cap, and mid-cap stocks tend to have different liquidity, volatility, and index inclusion profiles. Size alone does not determine quality, but it frames risk and how widely the stock is held.
Sector Comparison
Among Biotechnology names on our S&P 100 coverage, Regeneron Pharmaceuticals Inc's market cap of $79.94B can be compared with peers such as AMGN ($207.87B), GILD ($161.66B). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Biotechnology stocks.
Key Takeaways
- REGN is grouped in the Biotechnology sector for peer comparisons.
- Recent beta of 0.19 suggests lower-than-market price sensitivity.
- Trailing profit margin of 29.6% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for REGN.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Calculated Market Cap
$79.60B
Sector
Biotechnology
Other REGN Metrics
Frequently Asked Questions
What is REGN's market capitalization?
Market cap is the total market value of all outstanding shares. Regeneron Pharmaceuticals Inc's market cap is about $79.94B on this page's data date.
Is REGN a mega/large/mid/small cap?
With roughly $79.94B in market cap, Regeneron Pharmaceuticals Inc falls in the large-cap category in our size buckets (mega ≥$200B, large ≥$10B, mid ≥$2B). Size affects liquidity, index weight, and typical volatility.
How does market cap relate to REGN's risk profile?
Larger caps tend to have broader analyst coverage and deeper trading; smaller caps can offer growth but with higher idiosyncratic risk. Use market cap together with debt, cash flow, and Biotechnology position — not alone.
Calculate the market cap for any stock with our free calculator.
Open Market Cap Calculator →